Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 85 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 8685372

    Peptides and aptamers for targeting of neuron or nerves

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  2. US 8685403

    Insulin-like growth factor signaling and integrin

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  3. US 8685929

    Detecting CYP24 expression level as a marker for predisposition to cancer

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  4. US 8686045

    Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  5. US 8680083

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  6. US 8679476

    Interferon-β production modulating Listeria strains and methods for using same

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  7. US 8679545

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  8. US 8680082

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  9. US 8680291

    Diarylhydantoin compounds

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  10. US 8680058

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  11. US 8679510

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  12. US 8673301

    YKL-40 monoclonal antibody

    The Regents of the University of California · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  13. US 8663624

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  14. US 8663635

    N-cadherin: target for cancer diagnosis and therapy

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  15. US 8663602

    Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  16. US 8664251

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  17. US 8658626

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  18. US 8658622

    Methods and compositions for preventing and treating a disease related to glycan dysregulation

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  19. US 8658627

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  20. US 8653027

    Method of treatment of type-1 diabetes with humanin analogues

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  21. US 8653283

    Anticancer agents

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  22. US 8653057

    Prophylactic perioperative testosterone supplementation for protection of and recovery of function

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  23. US 8648112

    Therapeutic uses of urolithins

    The Regents of the University of California · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  24. US 8648119

    Controlled release immunomodulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.